Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients

References

• LouisDNPerryABurgerPInternational Society Of Neuropathology – Haarlem consensus guidelines for nervous system tumor classification and gradingBrain Pathol201424542943524990071
   PubMed Web of Science ®Google Scholar
• LouisDNPerryAReifenbergerGThe 2016 world health organization classification of tumors of the central nervous system: a summaryActa Neuropathol2016131680382027157931
   PubMed Web of Science ®Google Scholar
• ReifenbergerGCollinsVPPathology and molecular genetics of astrocytic gliomasJ Mol Med2004821065667015316624
   PubMed Web of Science ®Google Scholar
• NoushmehrHWeisenbergerDJDiefesKIdentification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaCancer Cell201017551052220399149
   PubMed Web of Science ®Google Scholar
• XuWYangHLiuYOncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenasesCancer Cell2011191173021251613
   PubMed Web of Science ®Google Scholar
• SchneiderTMawrinCScherlachCSkalejMFirschingRGliomas in adultsDtsch Arztebl Int20101074579980721124703
   PubMed Web of Science ®Google Scholar
• WellerMCloughesyTPerryJRWickWStandards of care for treatment of recurrent glioblastoma – are we there yet?Neuro Oncol201315142723136223
   PubMed Web of Science ®Google Scholar
• OsswaldMJungESahmFBrain tumour cells interconnect to a functional and resistant networkNature20155287580939826536111
   PubMed Web of Science ®Google Scholar
• SahmFCapperDJeibmannAAddressing diffuse glioma as a systemic brain disease with single-cell analysisArch Neurol201269452352622158715
   PubMedGoogle Scholar
• StuppRTaillibertSKannerAAMaintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trialJAMA2015314232535254326670971
   PubMed Web of Science ®Google Scholar
• HottingerAFPachecoPStuppRTumor treating fields: a novel treatment modality and its use in brain tumorsNeuro Oncol201618101338134927664860
   PubMed Web of Science ®Google Scholar
• MehtaMWenPNishikawaRReardonDPetersKCritical review of the addition of tumor treating fields (TT Fields) to the existing standard of care for newly diagnosed glioblastoma patientsCrit Rev Oncol Hematol2017111606528259296
   PubMed Web of Science ®Google Scholar
• StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med20053521098799615758009
   PubMed Web of Science ®Google Scholar
• PatilCGYiAElramsisyAPrognosis of patients with multifocal glioblastoma: a case-control studyJ Neurosurg2012117470571122920963
   PubMed Web of Science ®Google Scholar
• VinsonCMyakishevMAcharyaAMirAAMollJRBonovichMClassification of human B-ZIP proteins based on dimerization propertiesMol Cell Biol200222186321633512192032
   PubMed Web of Science ®Google Scholar
• GreeneLALeeHYAngelastroJMThe transcription factor ATF5: role in neurodevelopment and neural tumorsJ Neurochem20091081112219046351
   PubMed Web of Science ®Google Scholar
• AngelastroJMIgnatovaTNKukekovVGRegulated expression of ATF5 is required for the progression of neural progenitor cells to neuronsJ Neurosci200323114590460012805299
   PubMed Web of Science ®Google Scholar
• AngelastroJMMasonJLIgnatovaTNDownregulation of activating transcription factor 5 is required for differentiation of neural progenitor cells into astrocytesJ Neurosci200525153889389915829641
   PubMed Web of Science ®Google Scholar
• MasonJLAngelastroJMIgnatovaTNATF5 regulates the proliferation and differentiation of oligodendrocytesMol Cell Neurosci200529337238015950153
   PubMed Web of Science ®Google Scholar
• ShengZEvansSKGreenMRAn activating transcription factor 5-mediated survival pathway as a target for cancer therapy?Oncotarget20101645746021311102
   PubMedGoogle Scholar
• CatesCCAriasADNakayama WongLSRegression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptideOncotarget2016711127181273026863637
   PubMedGoogle Scholar
• Karpel-MasslerGHorstBAShuCA synthetic cell-penetrating dominant-negative ATF5 peptide exerts anticancer activity against a broad spectrum of treatment-resistant cancersClin Cancer Res201622184698471127126996
   PubMed Web of Science ®Google Scholar
• AngelastroJMCanollPDKuoJSelective destruction of glioblastoma cells by interference with the activity or expression of ATF5Oncogene200625690791616170340
   PubMed Web of Science ®Google Scholar
• ShengZLiLZhuLJA genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implicationsNat Med201016667167720495567
   PubMed Web of Science ®Google Scholar
• DongSNuttCLBetenskyRAHistology-based expression profiling yields novel prognostic markers in human glioblastomaJ Neuropathol Exp Neurol2005641194895516254489
   PubMed Web of Science ®Google Scholar
• HuaXMWangJQianDMDNA methylation level of promoter region of activating transcription factor 5 in gliomaJ Zhejiang Univ Sci B201516975776226365117
   PubMed Web of Science ®Google Scholar
• MonacoSEAngelastroJMSzabolcsMGreeneLAThe transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell linesInt J Cancer200712091883189017266024
   PubMed Web of Science ®Google Scholar
• IshiharaSYasudaMIshizuAIshikawaMShiratoHHagaHActivating transcription factor 5 enhances radioresistance and malignancy in cancer cellsOncotarget2015674602461425682872
   PubMedGoogle Scholar
• PlummerDLDispImage: A display and analysis tool for medical imagesRivasta di Neurorad19925489495
   Google Scholar
• SchindelinJArganda-CarrerasIFriseEFiji: an open-source platform for biological-image analysisNat Methods20129767668222743772
   PubMed Web of Science ®Google Scholar
• SchindelinJRuedenCTHinerMCEliceiriKWThe ImageJ ecosystem: An open platform for biomedical image analysisMol Reprod Dev2015827–851852926153368
   PubMed Web of Science ®Google Scholar
• SchneiderCARasbandWSEliceiriKWNIH Image to ImageJ: 25 years of image analysisNat Methods20129767167522930834
   PubMed Web of Science ®Google Scholar
• RuifrokACJohnstonDAQuantification of histochemical staining by color deconvolutionAnal Quant Cytol Histol200123429129911531144
   PubMed Web of Science ®Google Scholar
• van der LoosCMMultiple immunoenzyme staining: methods and visualizations for the observation with spectral imagingJ Histochem Cytochem200856431332818158282
   PubMed Web of Science ®Google Scholar
• GundryCNVandersteenJGReedGHPryorRJChenJWittwerCTAmplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotesClin Chem200349339640612600951
   PubMed Web of Science ®Google Scholar
• AdachiJMishimaKWakiyaKO6-methylguanine-DNA methyl-transferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatmentJ Neurooncol2012107114715321968944
   PubMed Web of Science ®Google Scholar
• LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) MethodMethods200125440240811846609
   PubMed Web of Science ®Google Scholar
• BardenCBShisterKWZhuBClassification of follicular thyroid tumors by molecular signature: results of gene profilingClin Cancer Res2003951792180012738736
   PubMed Web of Science ®Google Scholar
• MittalAKHegdeGVAounPMolecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalitiesInt J Mol Med200720446146917786276
   PubMed Web of Science ®Google Scholar
• KongXMengWZhouZOverexpression of activating transcription factor 5 in human rectal cancerExp Ther Med20112582783122977583
   PubMed Web of Science ®Google Scholar
• PersengievSPGreenMRThe role of ATF/CREB family members in cell growth, survival and apoptosisApoptosis20038322522812766482
   PubMed Web of Science ®Google Scholar
• DluzenDLiGTaceloskyDMoreauMLiuDXBCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent mannerJ Biol Chem201128697705771321212266
   PubMed Web of Science ®Google Scholar
• LiuDXQianDWangBYangJMLuZp300-Dependent ATF5 acetylation is essential for Egr-1 gene activation and cell proliferation and survivalMol Cell Biol201131183906391621791614
   PubMed Web of Science ®Google Scholar
• Friedmann-MorvinskiDGlioblastoma heterogeneity and cancer cell plasticityCrit Rev Oncog201419532733625404148
   PubMedGoogle Scholar
• StewartLAChemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trialsLancet200235993111011101811937180
   PubMed Web of Science ®Google Scholar
• StummerWMeinelTEweltCProspective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgeryJ Neurooncol20121081899722307805
   PubMed Web of Science ®Google Scholar
• HartMGGarsideRRogersGSteinKGrantRTemozolomide for high grade gliomaCochrane Database Syst Rev20134CD007415
   PubMed Web of Science ®Google Scholar
• WellerMRothPPreusserMVaccine-based immunotherapeutic approaches to gliomas and beyondNat Rev Neurol201713636337428497804
   PubMed Web of Science ®Google Scholar
• CarlssonSKBrothersSPWahlestedtCEmerging treatment strategies for glioblastoma multiformeEMBO Mol Med20146111359137025312641
   PubMed Web of Science ®Google Scholar
• Domingo-MusibayEGalanisEWhat next for newly diagnosed glioblastoma?Future Oncol201511243273328326558493
   PubMed Web of Science ®Google Scholar
• AriasALaméMWSantarelliLHenRGreeneLAAngelastroJMRegulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomasOncogene201231673975121725368
   PubMed Web of Science ®Google Scholar
• TseCShoemakerARAdickesJABT-263: a potent and orally bioavailable Bcl-2 family inhibitorCancer Res20086893421342818451170
   PubMed Web of Science ®Google Scholar
• YorkDSproulCDChikereNDickinsonPJAngelastroJMExpression and targeting of transcription factor ATF5 in dog gliomasVet Comp Oncol201816110210728480569
   PubMed Web of Science ®Google Scholar